MedPath

Surveillance HeartCare® Outcomes Registry

Active, not recruiting
Conditions
Heart Transplant Rejection
Interventions
Other: Standard of Care
Registration Number
NCT03695601
Lead Sponsor
CareDx
Brief Summary

This is an observational registry to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.

Detailed Description

HeartCare is a service which includes AlloMap® and AlloSure-Heart® to provide information to help clinicians to more comprehensively monitor heart transplant recipients for allograft rejection. An approach to surveillance using HeartCare provides information from two complementary measures; AlloMap is a gene-expression profile based measure of host immune activity and risk of acute rejection. AlloSure-Heart monitors graft injury. AlloMap is the first FDA cleared test and is the only non-invasive, blood test method recommended in the International Society for Heart and Lung Transplantation (ISHLT) guidelines for surveillance of heart transplant recipients for rejection. AlloSure-Heart measures donor-derived cell-free DNA (dd-cfDNA) to help discriminate acute cellular rejection and antibody-mediated rejection from no rejection. Patients who receive HeartCare, as part of their post-transplant management, will give informed consent for information on their outcomes and other relevant clinical information, found in their medical records, to be entered into a SHORE database for purposes of the study.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
2743
Inclusion Criteria
  1. Patients who are 15 years of age or older at the time of blood draw.
  2. Received a heart transplant (primary or repeat)
  3. Patients who have HeartCare initiated within 3 months post-transplant
Exclusion Criteria
  1. Patients who are pregnant at the time of blood draw.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ControlStandard of CareA historical control group will be matched to the estimated 1150 HeartCare group patients who complete at least two years of HeartCare surveillance use and inclusive of year 3 post-transplant clinical follow-up for outcome. The criteria for the matched controls will be based on allograft donor type, age, gender, ethnicity/race, and other clinical factors. Propensity scores will be used to perform the matching.
HeartCareStandard of CareDiagnostic Test: Heart Care 2300 patients managed with HeartCare (AlloMap® and AlloSure-Heart® )
Primary Outcome Measures
NameTimeMethod
Proportion of patients who develop de-novo DSA as a surrogate to clinical outcomes at 1, 3 and 5 years post-transplant.Dec-2026

The primary endpoint of the study is the proportion of patients who develop de-novo DSA as a surrogate to clinical outcomes at 1, 3 and 5 years post-transplant. The overall incidence of de-novo DSA is between 10-20% in the first year and 10-15% each year subsequently.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (67)

Mayo Clinic Rochester

🇺🇸

Rochester, Minnesota, United States

Medical City Dallas

🇺🇸

Dallas, Texas, United States

Mayo Clinic Arizona

🇺🇸

Phoenix, Arizona, United States

Baptist Health Arkansas

🇺🇸

Little Rock, Arkansas, United States

University of California San Diego

🇺🇸

La Jolla, California, United States

Cedars-Sinai Medical Center

🇺🇸

Los Angeles, California, United States

University of California, Los Angeles

🇺🇸

Los Angeles, California, United States

University of Southern California

🇺🇸

Los Angeles, California, United States

California Pacific Medical Center

🇺🇸

San Francisco, California, United States

University of California San Fransisco Medical Center

🇺🇸

San Francisco, California, United States

Stanford University

🇺🇸

Stanford, California, United States

Yale New Haven

🇺🇸

New Haven, Connecticut, United States

Medstar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Memorial Healthcare System

🇺🇸

Hollywood, Florida, United States

Mayo Clinic- Florida

🇺🇸

Jacksonville, Florida, United States

University of Miami

🇺🇸

Miami, Florida, United States

Advent Health

🇺🇸

Orlando, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

Piedmont Heart Institute

🇺🇸

Atlanta, Georgia, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

University of Chicago Medicine

🇺🇸

Chicago, Illinois, United States

Loyola University Medical Center

🇺🇸

Maywood, Illinois, United States

Advocate Christ Medical Center

🇺🇸

Oak Lawn, Illinois, United States

Indiana University School of Medicine

🇺🇸

Indianapolis, Indiana, United States

Ascension St. Vincent Hospital and Health Care Center

🇺🇸

Indianapolis, Indiana, United States

The University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

Ochsner Clinic Foundation

🇺🇸

New Orleans, Louisiana, United States

Tufts Medical Center

🇺🇸

Boston, Massachusetts, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

Spectrum Health

🇺🇸

Grand Rapids, Michigan, United States

St. Luke's Hospital of Kansas City

🇺🇸

Kansas City, Missouri, United States

Barnes Jewish Hospital, Washington University

🇺🇸

Saint Louis, Missouri, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

Northwell Health/ North Shore University Hospital

🇺🇸

Manhasset, New York, United States

NYU Langone Health

🇺🇸

New York, New York, United States

Icahn School of Medicine at Mount Sinai

🇺🇸

New York, New York, United States

Columbia University Irving Medical Center

🇺🇸

New York, New York, United States

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

University of North Carolina at Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

Wake Forest Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

The Ohio State University

🇺🇸

Columbus, Ohio, United States

Integris Baptist Medical Center

🇺🇸

Oklahoma City, Oklahoma, United States

Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

Penn State Health Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Allegheny-Singer Research Institute

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Stern Cardiovascular Foundation

🇺🇸

Germantown, Tennessee, United States

Saint Thomas Health

🇺🇸

Nashville, Tennessee, United States

Ascension Seton

🇺🇸

Austin, Texas, United States

Baylor Research Institute

🇺🇸

Dallas, Texas, United States

UT Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

Baylor St. Luke's Medical Center

🇺🇸

Houston, Texas, United States

Houston Methodist Research Institute

🇺🇸

Houston, Texas, United States

UTHealth/ Memorial Hermann Hospital

🇺🇸

Houston, Texas, United States

Methodist Healthcare Systems of San Antonio

🇺🇸

San Antonio, Texas, United States

Intermountain Heart Institute

🇺🇸

Murray, Utah, United States

Inova Fairfax Medical Campus

🇺🇸

Falls Church, Virginia, United States

Sentara Cardiovascular Research Institute

🇺🇸

Norfolk, Virginia, United States

University of Washington

🇺🇸

Seattle, Washington, United States

University of Wisconsin School of Medicine and Public Health

🇺🇸

Madison, Wisconsin, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Aurora Research Institute

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath